PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25724N0385Accu-check INFORM II glucose control and — Roche Diagnostics Corp

Roche Diagnostics Corp holds $245.9M across 1,391 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79722D0128. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Jun 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

257-Network Contract Office 17 (36C257)

Awarding office

Roche Diagnostics Corp

Recipient

Jun 30, 2027

PoP end

$131K

Obligated

$326K

Potential

325413

NAICS

6550

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Roche Diagnostics Corp — $90

Contract facts

Federal

Contract number36C25724N0385

Also listed as36C257-24-N-0385

Also listed as36F79722D0128-36C25724N0385

Agency257-Network Contract Office 17 (36C257)

Awarding office257-Network Contract Office 17 (36C257)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentRoche Diagnostics Corp

CAGE51169

UEIJDMDFEZBYH36

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDV36F79722D0128

Place of performanceINDIANAPOLIS IN

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJul 3, 2024

PoP end (current)Jun 30, 2027

PoP end (w/ options)Jun 30, 2029

Obligated$131K

Current value$196K

Potential value$326K

ACCU-CHECK INFORM II GLUCOSE CONTROL AND SOLUTIONS EXERCISE OPTION 1 is a federal award for 257-Network Contract Office 17 (36C257) held by Roche Diagnostics Corp. Estimated value $326K ($131K obligated). Current period of performance ends Jun 30, 2027 (potential Jun 30, 2029). Last award drew 1 bidder. Place of performance: INDIANAPOLIS IN.

ACCU-CHECK INFORM II GLUCOSE CONTROL AND SOLUTIONS EXERCISE OPTION 1

Recompete timing

Public

● Expiring in 313 days

Current PoP ends Jun 30, 2027 (313 days remaining). Agencies typically plan 12–18 months ahead — at 10.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Roche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($245.9M) · all agencies

Department of Veterans Affairs (VA)$154.1M · 63%Department of Defense (DOD)$77.5M · 32%Department of Health and Human Services (HHS)$10.4M · 4%Department of Justice (DOJ)$3.0M · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C26225N0151

CHEMISTRY IMMUNOASSAY SYSTEM CPT

$5.9M

Aug 31, 2026

36C25025N1021

FSS-BPA ROCHE COBAS 4800 REAGENTS, CONSUMABLES, CONTROLS.

$600K

Aug 31, 2026

FA480321F0055

ROCHE COVID TEST KITS

$159K

Aug 31, 2026

36C25025N1000

COBA REAGENTS/CONSUMABLES

$135K

Aug 31, 2026

36C25726P0473

BENCHMARK ULTRA PLUS

$132K

Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25724N0385?

36C25724N0385 (Accu-check INFORM II glucose control and) is a 257-Network Contract Office 17 (36C257) award with a potential value of $326K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-24-N-0385?

36C257-24-N-0385 is the dashed form of PIID 36C25724N0385 (Accu-check INFORM II glucose control and), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25724N0385?

257-Network Contract Office 17 (36C257) awarded 36C25724N0385 to Roche Diagnostics Corp (potential $326K).

Who is the incumbent on 36C25724N0385?

Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2027.

When does Roche Diagnostics Corp’s 36C25724N0385 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Feb 26, 2026